Vestibular Schwannoma–Related Increased Labyrinthine Postgadolinium 3D-FLAIR Signal Intensity and Association with Hearing Impairment

References

1. 1.↵
   1. Marinelli JP,
   2. Grossardt BR,
   3. Lohse CM, et al

   . Prevalence of sporadic vestibular schwannoma: reconciling temporal bone, radiologic, and population-based studies. Otol Neurotol 2019;40:384–90 doi:10.1097/MAO.0000000000002110 pmid:30688755

   CrossRefPubMedGoogle Scholar
2. 2.↵
   1. Marinelli JP,
   2. Lohse CM,
   3. Grossardt BR, et al

   . Rising incidence of sporadic vestibular schwannoma: true biological shift versus simply greater detection. Otol Neurotol 2020;41:813–47 doi:10.1097/MAO.0000000000002626 pmid:32150020

   CrossRefPubMedGoogle Scholar
3. 3.↵
   1. Carlson ML,
   2. Link MJ

   . Vestibular schwannomas. N Engl J Med 2021;384:1335–48 doi:10.1056/NEJMra2020394 pmid:33826821

   CrossRefPubMedGoogle Scholar
4. 4.↵
   1. Floc’h JL,
   2. Tan W,
   3. Telang RS, et al

   . Markers of cochlear inflammation using MRI. Magn Reson Imaging 2014;39:150–61 doi:10.1002/jmri.24144

   CrossRefPubMedGoogle Scholar
5. 5.↵
   1. Hannan CJ,
   2. Lewis D,
   3. O’Leary C, et al

   . The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv 2020;2:vdaa023 doi:10.1093/noajnl/vdaa023 pmid:32642684

   CrossRefPubMedGoogle Scholar
6. 6.↵
   1. Lassaletta L,
   2. Calvino M,
   3. Morales-Puebla JM, et al

   . Biomarkers in vestibular schwannoma–associated hearing loss. Front Neurol 2019;10:978 doi:10.3389/fneur.2019.00978 pmid:31620068

   CrossRefPubMedGoogle Scholar
7. 7.↵
   1. Patel NS,
   2. Huang AE,
   3. Dowling EM, et al

   . The influence of vestibular schwannoma tumor volume and growth on hearing loss. Otolaryngol Head Neck Surg 2020;162:530–37 doi:10.1177/0194599819900396 pmid:31986971

   CrossRefPubMedGoogle Scholar
8. 8.↵
   1. Bowen AJ,
   2. Carlson ML,
   3. Lane JI

   . Inner ear enhancement with delayed 3D-FLAIR MRI imaging in vestibular schwannoma. Otol Neurotol 2020;41:1274–79 doi:10.1097/MAO.0000000000002768 pmid:32925857

   CrossRefPubMedGoogle Scholar
9. 9.↵
   1. Bhadelia RA,
   2. Tedesco KL,
   3. Hwang S, et al

   . Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma. AJNR Am J Neuroradiol 2008;29:720–23 doi:10.3174/ajnr.A0968

   CrossRefPubMedGoogle Scholar
10. 10.↵
    1. Welby JP,
    2. Benson JC,
    3. Lohse CM, et al

    . Increased labyrinthine T1 postgadolinium signal intensity is associated with the degree of ipsilateral sensorineural hearing loss in patients with sporadic vestibular schwannoma. AJNR Am J Neuroradiol 2023;44:317–22 doi:10.3174/ajnr.A7800 pmid:36797029

    Abstract/FREE Full TextGoogle Scholar
11. 11.↵
    1. Luong PQ,
    2. Cabrera CI,
    3. Patil N, et al

    . MRI T2-weighted cochlear intensity as a predictor of hearing loss with vestibular schwannoma patients. Ann Otol Neurotol 2021;4:19–25 doi:10.1055/s-0041-1735394

    CrossRefGoogle Scholar
12. 12.↵
    1. Osawa I,
    2. Kozawa E,
    3. Tanaka S, et al

    . Signal and morphological changes in the endolymph of patients with vestibular schwannoma on non-contrast 3D FLAIR at 3 Tesla. BMC Med Imaging 2021;21:135 doi:10.1186/s12880-021-00670-9 pmid:34563164

    CrossRefPubMedGoogle Scholar
13. 13.↵
    1. Yamazaki M,
    2. Naganawa S,
    3. Kawai H, et al

    . Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855–63 doi:10.1007/s00234-009-0588-6 pmid:19727694

    CrossRefPubMedGoogle Scholar
14. 14.↵
    1. Miller ME,
    2. Mafee MF,
    3. Bykowski J, et al

    . Hearing preservation and vestibular schwannoma: intracochlear FLAIR signal relates to hearing level. Otol Neurotol 2014;35:348–52 doi:10.1097/MAO.0000000000000191 pmid:24366469

    CrossRefPubMedGoogle Scholar
15. 15.↵
    1. Tu NCY,
    2. Bobarnac Dogaru G,
    3. Huang P, et al

    . Cochlear FLAIR signal changes in hearing preservation vestibular schwannoma surgery. Otol Neurotol 2019;40:375–83 doi:10.1097/MAO.0000000000002102 pmid:30664035

    CrossRefPubMedGoogle Scholar
16. 16.↵
    American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 1995;113:179–80

    CrossRefPubMedWeb of ScienceGoogle Scholar
17. 17.↵
    1. Benson JC,
    2. Carlson ML,
    3. Lane JI

    . Peritumoral signal on postcontrast FLAIR images: description and proposed biomechanism in vestibular schwannomas. AJNR Am J Neuroradiol 2023;44:1171–75 doi:10.3174/ajnr.A7979 pmid:37652582

    Abstract/FREE Full TextGoogle Scholar
18. 18.↵
    1. Fujita T,
    2. Seist R,
    3. Kao SY, et al

    . miR-431 secreted by human vestibular schwannomas increases the mammalian inner ear’s vulnerability to noise trauma. Front Neurol 2023;14:1268359 doi:10.3389/fneur.2023.1268359 pmid:37885485

    CrossRefPubMedGoogle Scholar
19. 19.↵
    1. Ölander C,
    2. Edvardsson Rasmussen J,
    3. Eriksson PO, et al

    . The proteome of the human endolymphatic sac endolymph. Sci Rep 2021;11:11850 doi:10.1038/s41598-021-89597-3 pmid:34088924

    CrossRefPubMedGoogle Scholar
20. 20.↵
    1. Saba ES,
    2. Marinelli JP,
    3. Lohse CM, et al

    . Quantifying tertiary referral center bias in vestibular schwannoma research. Otol Neurotol 2020;41:258–64 doi:10.1097/MAO.0000000000002496 pmid:31789811

    CrossRefPubMedGoogle Scholar